Tirzepatide by Eli Lilly reduces heart failure risk in adults with HFpEF and obesity, showing promising results for both ...
Jaime Merchan, MD, discusses the background and findings from the LITESPARK-013 trial of belzutifan for the treatment of patients with advanced clear cell renal cell carcinoma.
A study testing a new nasal spray form of the medication bumetanide, a commonly prescribed diuretic, was found to be as safe ...
In the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking ...
News Medical on MSN8h
Tirzepatide improves heart health and function in obese HFpEF patientsIn the international SUMMIT trial, adults with heart failure preserved ejection fraction (HFpEF) and obesity taking tirzepatide for up to 3 years had a reduced combined risk of worsening heart failure ...
HOLLISTER, Calif., Nov. 18, 2024 /PRNewswire/ -- The San Benito Health Care District (the "District") announced today that Measure X has received voter approval, authorizing the District to negotiate ...
Welcome to the UK's Official Charts! In addition to the Official Singles and Albums Chart, did you know the Official Charts Company compiles 50+ charts every week, spanning different genres and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback